| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087886A1 Therapeutic agent for rheumatoid arthritis |
| 08/12/2009 | EP2086983A2 Fused ring compounds for inflammation and immune-related uses |
| 08/12/2009 | EP2086942A2 Novel compounds |
| 08/12/2009 | EP2086935A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 08/12/2009 | EP2086561A1 Topical formulation and uses thereof |
| 08/12/2009 | EP2086540A1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 08/12/2009 | EP1931348A4 Monocyclic and bicyclic compounds and methods of use |
| 08/12/2009 | EP1913155A4 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 08/12/2009 | EP1904077B1 Modulating responsiveness to steroids |
| 08/12/2009 | EP1850827A4 Composition for treating and preventing periodontal disease and method of use |
| 08/12/2009 | EP1831209B1 Cdc25 phosphatase inhibitors |
| 08/12/2009 | EP1778686B9 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 08/12/2009 | EP1663238B1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 08/12/2009 | EP1550672B1 Chimeric antagonist anth1 |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1501774B1 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | EP0674505B2 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| 08/12/2009 | CN101506239A Antihuman alpha9 integrin antibody and use of the same |
| 08/12/2009 | CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses |
| 08/12/2009 | CN101506176A 2-anilino-4-aminoalkyleneaminopyrimidines |
| 08/12/2009 | CN101506168A Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/12/2009 | CN101503736A Use of retinoic acid induced gene I, signal pathway mediated by coding protein thereof |
| 08/12/2009 | CN101503369A Method for preparing vanillyl acidamide compounds by interfacial reaction |
| 08/12/2009 | CN101502615A Plaster for traumatic injury and bone fracture |
| 08/12/2009 | CN101502604A Chinese herbal medicine preparation for treating rheumatism |
| 08/12/2009 | CN101502602A Viper wind-dispelling plaster |
| 08/12/2009 | CN101502587A Pharmaceutical combination and preparation method thereof |
| 08/12/2009 | CN101502571A Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof |
| 08/12/2009 | CN101502546A Ginseng (root) oligosacchride preparation and novel use thereof |
| 08/12/2009 | CN101502545A Method for preparing Chinese medicine for resisting cancer and treating cancer ache |
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502504A Nimesulide enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502499A Ibuprofen percutaneous release patch and preparation method thereof |
| 08/12/2009 | CN101502498A Curcumin preparation for percutaneous administration and preparation method thereof |
| 08/12/2009 | CN101502490A Ketoprofen bioadhesive gel microsphere and preparation method thereof |
| 08/12/2009 | CN101502324A Kava pepper extract effervescent tablet and technique for preparing the same |
| 08/12/2009 | CN100526982C Positive-working photoimageable bottom antireflective coating |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525815C A medicinal wine capable of treating multiple diseases |
| 08/12/2009 | CN100525805C Externally applied plaster for stopping muscles and bones pain |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525765C Lappaconitine hydrobromide dispersible tablet and its preparing method |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525755C Coated tablets |
| 08/12/2009 | CN100525749C Freeze-drying powder injection for treating calor febrilis and its production |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572815 Amide derivative |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572812 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |
| 08/11/2009 | US7572804 Macrolides |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572790 Biphenyl carboxylic amide p38 kinase inhibitors |
| 08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572470 Licorice extract for use as a medicament |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2447614C A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2321263C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/06/2009 | WO2009097233A1 Imidazopyrazines as protein kinase inhibitors |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009096315A1 Adhesive patch |
| 08/06/2009 | WO2009095437A1 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 08/06/2009 | WO2009095269A1 Use of tetrahydropyrimidines |
| 08/06/2009 | WO2009067317A3 Use of levocabastine for modulating generation of pro- inflammatory cytokines |
| 08/06/2009 | WO2009063495A3 Substituted indole and its derivatives as cannabinoid modulators |
| 08/06/2009 | WO2009047791A3 Toll like receptor (tlr) signaling antagonist |
| 08/06/2009 | WO2009043463A3 Use of gluten exorphin c : as a therapeutic agent |
| 08/06/2009 | WO2009040702A3 Pharmaceutical compositions of rhein or diacerein |
| 08/06/2009 | WO2009035497A3 Disease related cysteine modifications and uses thereof |
| 08/06/2009 | WO2009033795A3 Use of a obestatin as a therapeutic agent |
| 08/06/2009 | WO2008109532A8 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 08/06/2009 | WO2008109382A8 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof |
| 08/06/2009 | US20090197960 Method of Inhibiting Polyneuropathic Pain with 3-(2-Dimethylaminomethylcyclohexyl) Phenol |
| 08/06/2009 | US20090197921 USE OF NICOTINE, ANALOGUES, THEREOF, PRECURSORS THEREOF OR DERIVATIVES THEROF IN THE TREATMENT OF VARIOUS PATHOLOGICAL PROCESSES CAPABLE OF IMPROVEMENT WITH a-MSH ADMINISTERED IN PROPHYLACTIC OR THERAPEUTIC FORM |
| 08/06/2009 | US20090197889 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 08/06/2009 | US20090197885 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| 08/06/2009 | US20090197884 Compounds Useful as Antagonists of CCR2 |
| 08/06/2009 | US20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use |
| 08/06/2009 | US20090197832 Polymer mixtures of anionic and cationic polysaccharides and use thereof |
| 08/06/2009 | US20090197814 Chemically modified peptides derived from the chemokine CCL14 (HCC-1); replacement of the ultimate N-terminal amino acid of CCL14[9-74] by nonanoic acid (NNY) converts it into a potent agonist; inactivation of the chemokine receptor; antiinflammatory agents |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196847 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof |
| 08/06/2009 | DE102008006780A1 Verwendung von Tetrahydropyrimidinen Use of tetrahydropyrimidines |
| 08/06/2009 | CA2713946A1 Adhesive patch |